Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

United States

 

Kooth continues US expansion with Kismet acquisition

UK-based listed digital mental healthcare group Kooth is continuing its expansion into the US market with the acquisition of Kismet, a small US digital mental healthcare company that specialises in under 12s. Kooth’s CEO Kate Newhouse tells us the acquisition will expand the capabilities and reach of Kooth’s US platform Soluna.

Boots to be spun off from WBA

US PE firm Sycamore Partners has completed its $10 billion take-private of Walgreens Boots Alliance (WBA), a US healthcare, pharmacy and retail company that owns UK pharmacy chain Boots. Sycamore has decided to separate off Boots, as expected.

From 0 to 250%: EU pharma and Trump’s tariffs

Last month, HBI covered how EU tariff negotiations would affect pharma prices. At that time, Donald Trump had been threatening a 50% tariff on all EU imports and a 200% tariff on pharmaceutical imports, creating much uncertainty around the final state of the trade deal. On Tuesday, however, Trump told CNBC that while the tariffs on pharmaceuticals may be “small” initially, in a year's time they will be increased to 150% and then 250%.

Omega confirms it acquired 45 Four Seasons care homes

US healthcare REIT Omega Healthcare Investors has confirmed it was the acquirer of 45 of the final batch of 47 UK care homes that were sold earlier this year in the final stage of the years-long liquidation of Four Seasons, formerly the UK’s largest for-profit elderly care group.

Former 23andMe CEO makes bid with sale reopened

The sale of genetics-led consumer healthcare and biotech company 23andMe has taken an unexpected turn, with bidding reopened and its co-founder and former CEO Anne Wojcicki putting in a nearly $50 million higher offer than the previously confirmed buyer. 

Find Us